1. Home
  2. GIS vs GNLX Comparison

GIS vs GNLX Comparison

Compare GIS & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GIS
  • GNLX
  • Stock Information
  • Founded
  • GIS 1866
  • GNLX 2001
  • Country
  • GIS United States
  • GNLX United States
  • Employees
  • GIS N/A
  • GNLX N/A
  • Industry
  • GIS Packaged Foods
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GIS Consumer Staples
  • GNLX Health Care
  • Exchange
  • GIS Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • GIS 36.7B
  • GNLX 103.6M
  • IPO Year
  • GIS N/A
  • GNLX 2023
  • Fundamental
  • Price
  • GIS $63.72
  • GNLX $2.27
  • Analyst Decision
  • GIS Hold
  • GNLX Strong Buy
  • Analyst Count
  • GIS 16
  • GNLX 4
  • Target Price
  • GIS $70.33
  • GNLX $18.25
  • AVG Volume (30 Days)
  • GIS 4.8M
  • GNLX 142.7K
  • Earning Date
  • GIS 12-18-2024
  • GNLX 11-14-2024
  • Dividend Yield
  • GIS 3.77%
  • GNLX N/A
  • EPS Growth
  • GIS 11.96
  • GNLX N/A
  • EPS
  • GIS 4.60
  • GNLX N/A
  • Revenue
  • GIS $19,901,300,000.00
  • GNLX $8,000.00
  • Revenue This Year
  • GIS $1.47
  • GNLX N/A
  • Revenue Next Year
  • GIS N/A
  • GNLX N/A
  • P/E Ratio
  • GIS $13.84
  • GNLX N/A
  • Revenue Growth
  • GIS N/A
  • GNLX N/A
  • 52 Week Low
  • GIS $61.48
  • GNLX $1.60
  • 52 Week High
  • GIS $75.90
  • GNLX $16.60
  • Technical
  • Relative Strength Index (RSI)
  • GIS 37.76
  • GNLX 38.68
  • Support Level
  • GIS $62.81
  • GNLX $2.13
  • Resistance Level
  • GIS $65.09
  • GNLX $2.80
  • Average True Range (ATR)
  • GIS 1.24
  • GNLX 0.20
  • MACD
  • GIS -0.12
  • GNLX -0.04
  • Stochastic Oscillator
  • GIS 18.76
  • GNLX 14.21

About GIS General Mills Inc.

General Mills is a global packaged food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2024, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: